Nathan Spencer
Physical Medicine & Rehabilitation · Richland, WANPI 1376038109
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,614 of the $2,263 with a category attached, or 71.3%. Pacira Pharmaceuticals Incorporated accounts for 77.4% of it on its own, with 7 other manufacturers making up the rest. 2024 is the largest year on record at $1,755, more than ten times the $12 reported in 2020.
Across 20 payments — averaging $113.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- Ipsen Biopharmaceuticals, Inc$238
- Averitas Pharma Inc.$77
- Collegium Pharmaceutical, Inc.$54
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$54
- GRT US Holding, Inc.$45
- plus $42 from 2 others
What the payments were for
- Travel & lodging$1,61471%
- Food & beverage$65029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,263 in reported general payments places this provider in the 85th percentile of 260 physical medicine & rehabilitation providers in Washington.
See all physical medicine & rehabilitation providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 12 | $16,986 |
| BelbucaBuprenorphine Hcl | 12 | $9,256 |
| Pregabalin | 236 | $4,879 |
| Xtampza ErOxycodone Myristate | 14 | $2,631 |
| Baclofen | 130 | $2,417 |
| Duloxetine Hcl | 143 | $2,067 |
| OxycontinOxycodone Hcl | 11 | $1,728 |
| Gabapentin | 87 | $1,341 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 28 | $633 |
| Oxycodone Hcl | 54 | $589 |
| Diclofenac Sodium | 27 | $509 |
| Tizanidine Hcl | 13 | $401 |
| Celecoxib | 12 | $345 |
| Meloxicam | 63 | $323 |
| Nortriptyline Hcl | 16 | $238 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $54 | $11,88726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 260 physical medicine & rehabilitation providers in Washington.
Other physical medicine & rehabilitation in Richland
- Wing ChauRichland$2K
- Nassim RadSeattle$231K
- Nelson HagerTacoma$186K
- Martin ChildersSeattle$170K
- Theodore BrownKirkland$62K
- Angeli MayadevSeattle$51K
- Ronan CahillBellevue$22K
- Karen StanekSpokane$19K
- Beno KuharichSilverdale$17K
- Ib OddersonBellevue$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.